Purchase Order 75D30118P03000
- Not listed
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $193,000.00 firm fixed price purchase order to Pacific Biosciences of California, Inc. to upgrade their PacBio Sequel System. This contract does not have a set-aside designation. Pacific Biosciences is a manufacturer of specialized scientific equipment, reagents, and services associated with their Sequel and Sequel II DNA/RNA sequencing systems. They have fulfilled over $10 million in federal...
- This contract award is to Pacific Biosciences of California, Inc., a for-profit manufacturer, for the delivery of their Sequel and Sequel II DNA/RNA sequencing platforms and associated consumables to the Centers for Disease Control and Prevention (CDC). The $250,000.00 firm-fixed price purchase order has a performance period ending on December 31, 2025. Pacific Biosciences has established itself as a key supplier of specialized sequencing solutions to various federal agencies, as evidenced by...
- This federal contract award to Pacific Biosciences of California, Inc. is for the delivery of their Sequel and Sequel II DNA/RNA sequencing platforms, associated reagents, and support services. The $84,000.00 purchase order was issued by the Centers for Disease Control and Prevention (CDC) and does not have a set-aside designation. Pacific Biosciences is the original equipment manufacturer for their proprietary single molecule, real-time (SMRT) sequencing technology. The company has...
- This federal contract award, valued at $84,000.00, was issued by the Centers for Disease Control and Prevention (CDC) to Pacific Biosciences of California, Inc. for a service agreement related to their Pacific Biosciences RS DNA Sequencer. The contract is a firm fixed-price purchase order without a set-aside designation. Pacific Biosciences is the original equipment manufacturer of the Sequel and Sequel II DNA/RNA sequencing platforms, which are utilized by various federal agencies to support...
- This federal contract award to Pacific Biosciences of California, Inc. is for the provision of supplies related to SMRT sequencing technology. The $142,982.42 firm fixed price purchase order was issued by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services and has a period of performance ending on March 31, 2016. Pacific Biosciences is the original equipment manufacturer for their proprietary Sequel and Sequel II DNA/RNA sequencing platforms, which are utilized by...
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $165,103.00 firm fixed-price purchase order contract to Pacific Biosciences of California, Inc. (PacBio), a manufacturer of goods, for the provision of reagents. The contract has a completion date of September 30, 2023. PacBio is a prime contractor that has fulfilled over $10 million in federal contracts and delivery orders to provide sequencing instruments, consumables, and associated services...
- The Department of Health and Human Services Food and Drug Administration awarded a $433,950.00 firm fixed price purchase order to Pacific Biosciences of California, Inc. to provide a DNA sequencer with accessories. The contract has no set-aside designation and was completed on August 29, 2019. Pacific Biosciences is a manufacturer of specialized scientific equipment, reagents, and services for DNA/RNA sequencing. They have fulfilled over $10 million in federal contracts, including with the...
- This contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Pacific Biosciences of California, Inc. for laboratory equipment maintenance services for the agency's PacBio RSII and Sequel DNA sequencing systems. The $119,000 firm fixed-price purchase order has a completion date of September 18, 2020. Pacific Biosciences is a manufacturer of specialized scientific equipment, reagents, and sequencing services that has fulfilled over $10...
- This is a firm-fixed price contract award to Pacific Biosciences of California, Inc. by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services. The $105,940 contract is for the provision of PacBio reagents, which are used in Pacific Biosciences' proprietary Sequel and Sequel II DNA/RNA sequencing platforms. These specialized sequencing systems and associated consumables are utilized by various federal civilian and defense agencies to support genomic research...
- This contract is a Blanket Purchase Agreement (BPA) call awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Pacific Biosciences of California, Inc., a manufacturer of specialized scientific equipment, reagents, and services associated with their Sequel and Sequel II DNA/RNA sequencing systems. The contract has a potential value of $168,880.71 and is for the delivery of sequencing instruments, consumables, and associated services to support...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to Pacific Biosciences of California, Inc., a for-profit manufacturer of specialized scientific equipment, reagents, and services. The $357,500.00 contract is for the provision of Pacific Biosciences' Sequel system, which includes the Sequel DNA/RNA sequencing instrument and associated consumables. The contract has no set-aside designation and is to be performed in Atlanta, GA. Pacific Biosciences has previously fulfilled over $10 million in federal contracts to provide sequencing instruments, consumables, and services to agencies such as the USDA, FDA, NIH, and DoD. The company holds two IDIQ contracts, one with USDA ARS and another with FDA, to provide its Sequel-Sequel II product family on an as-needed basis to support the agencies' genomic research programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $0 | 3/8/22 | |
| Not listed | Not listed | $357.5k | 8/21/18 |